8-K
SAIL SM (Stakeholder Aligned Initial Listing) securities, each consisting of one share of Class A Common Stock, $0.0001 par value, and one-fifth of Redeemable Warrants included as part of the SAILSMsecurities, each whole warrant exercisable for one share of Class A Common Stock 0001841389 false 0001841389 2022-04-11 2022-04-11 0001841389 revh:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneFifthOfOneRedeemableWarrantMember 2022-04-11 2022-04-11 0001841389 us-gaap:CommonClassAMember 2022-04-11 2022-04-11 0001841389 revh:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2022-04-11 2022-04-11

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 11, 2022

 

 

REVOLUTION HEALTHCARE ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40190   86-1403778

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

20 University Road

Cambridge, Massachusetts

  02138
(Address of principal executive offices)   (Zip Code)

(617) 234-7000

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange

on which registered

SAILSM (Stakeholder Aligned Initial Listing) securities, each consisting of one share of Class A common Stock, $0.0001 par value, and one-fifth of one redeemable warrant to acquire one share of Class A Common Stock    REVHU    The NASDAQ Stock Market LLC
Class A Common Stock included as part of the SAILSM securities    REVH    The NASDAQ Stock Market LLC
Redeemable Warrants included as part of the SAILSM securities, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50    REVHW    The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On April 11, 2022, Robert Nelsen and Hemant Taneja resigned as members of the Board of Directors (the “Board”) of Revolution Healthcare Acquisition Corp. (the “Company”) effective immediately.

Mr. Nelsen’s and Mr. Taneja’s resignations did not result from any disagreements with the Company on any matter relating to its operations, policies, or practices. The size of the Board is now five following Mr. Nelsen’s and Mr. Taneja’s departures. Following their resignation from the Board, Mr. Nelsen and Mr. Taneja shall serve as observers to the Board.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 11, 2022

 

REVOLUTION HEALTHCARE ACQUISITION CORP.
By:  

/s/ Mark McDonnell

Name:   Mark McDonnell
Title:   Chief Financial Officer